[Involvement of PPARgamma in the pathogenesis of hypertension and hypertensive target-organ damage].
Itoh
Hiroshi
H
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
D017667:Adipocytes / Q000166:cytology; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D002454:Cell Differentiation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007333:Insulin Resistance; D020738:Leptin / Q000378:metabolism; D008024:Ligands; D050356:Lipid Metabolism; D008262:Macrophage Activation; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000209:etiology; D009389:Neovascularization, Pathologic; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology*; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D014157:Transcription Factors / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D020738:Leptin; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors; D042461:Vascular Endothelial Growth Factor A